Modeling immunity in microphysiological systems

Exp Biol Med (Maywood). 2023 Nov;248(22):2001-2019. doi: 10.1177/15353702231215897. Epub 2024 Jan 2.

Abstract

There is a need for better predictive models of the human immune system to evaluate safety and efficacy of immunomodulatory drugs and biologics for successful product development and regulatory approvals. Current in vitro models, which are often tested in two-dimensional (2D) tissue culture polystyrene, and preclinical animal models fail to fully recapitulate the function and physiology of the human immune system. Microphysiological systems (MPSs) that can model key microenvironment cues of the human immune system, as well as of specific organs and tissues, may be able to recapitulate specific features of the in vivo inflammatory response. This minireview provides an overview of MPS for modeling lymphatic tissues, immunity at tissue interfaces, inflammatory diseases, and the inflammatory tumor microenvironment in vitro and ex vivo. Broadly, these systems have utility in modeling how certain immunotherapies function in vivo, how dysfunctional immune responses can propagate diseases, and how our immune system can combat pathogens.

Keywords: Microphysiological systems; immunity; inflammatory diseases; lymphatics; tissue interfaces; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Immunotherapy*
  • Microphysiological Systems*
  • Tumor Microenvironment